Stem cells have the potential to replace these dead cells from the cardiac tissue.
Advertisement
What do you think of “factory-produced” stem cells and the advancements in the regenerative medicine field?
Experiencing a major heart attack usually kills roughly five billion heart cells. This means that stem cells could be able to fix the damage caused by a heart attack. This could benefit patients who are now undergoing similar procedures.
To match supply with demand, scientists have been looking for polymer substrates on which human pluripotent stem cells can be concurrently grown in numbers in the billions, yet free from possible contamination.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Professor Alexander said: “The possibilities for regenerative medicine are still being researched in the form of clinical trials”. “What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective”.
These new materials have shown great promise in the laboratory. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
The artificial material has the ability to provide in mass these stem cells for clinical use, such as treating the brain, heart or liver. Stem cells are highly efficient in treatments for diabetes, Alzheimer’s disease, spinal cord injury fix, baldness reversal and the list can go on with Parkinson’s disease and spinal cord injury fix. “However, with this kind of product, if we can get it commercialized and validated by the regulators it could be helping patients in two to three years”.
Stem cell treatments would work to replace those cells and dramatically increase one’s chances of survival, and the man-made material could allow for the creation of off-the-shelf products that could treat diseases of the brain, heart, and liver, to name a few.
Stem cells come in embryonic and adult variations, with each having a set of properties that make it suitable for particular uses.
Advertisement
Upcoming events already accessible through stemcellconference.org include the Global Stem Cells Group Regenerative Medicine Symposiums to be held September 3 in Santiago, Chile; October 9 in Barcelona, Spain; October 15 in Buenos Aires, Argentina; and March 19, 2016 in San Jose, Costa Rica.
